Background: Non-insulin-dependent diabetes mellitus (NIDDM) is associated with an increased incidence of cognitive impairment. Methods: A retrospective chart review study involving 707 patients admitted for rehabilitation after an ischemic stroke. Cognitive status was assessed by the Mini-Mental State Examination (MMSE), and scores lower than 24 points were considered suggestive of cognitive impairment. Results: Age, gender, NIDDM, dementia, and previous stroke emerged as the only statistically significant parameters differing between those with MMSE score lower than 24 or higher. After adjusting for confounding variables, NIDDM (odds ratio 1.46, 95% CI 1.05-2.05, P ¼ .02) was associated with an increased risk of cognitive impairment. Conclusions: Our findings suggest that NIDDM is independently associated with lower MMSE scores in ischemic stroke patients. It identifies individuals in need of specifically targeted interventions and may assist in selecting and developing resources for cognitively impaired diabetic patients.
Introduction
Non-insulin-dependent diabetes mellitus (NIDDM) is common in the elderly individuals. 1 According to recent data from the National Health and Nutrition Examination Survey (NHANES), the prevalence of the disease in Americans aged 60 and older is nearly 20%. 2 Although already known to be associated with major clinical sequelae, such as vascular and renal diseases, NIDDM has been identified in recent largescale epidemiological studies [3] [4] [5] [6] [7] as a significant risk factor for age-related cognitive impairment, cognitive decline, and dementia. Some of the cognitive effects of NIDDM may result from vascular consequences of the disease, because vascular factors are known contributors to cognitive impairment and dementia. 8, 9 In 2 large cohorts of 12 233 community-dwelling older men and women, NIDDM status and longer duration were strongly associated with worse cross-sectional cognitive performance, as well as greater decline rates of general cognition in men and women. The observed effect of NIDDM was cognitively equivalent to aging by 3 years. 10 Several potential biological explanations have been proposed for a relationship between NIDDM and diminished cognitive function. One important potential explanation could be the indirect effect of diabetes mellitus (DM) on cognition through clinical or subclinical vascular disease, because the disease associated with cerebral microvascular and macrovascular damage, both of which contribute to cognitive decline. 11 However, there is growing evidence that abnormal insulin regulation, a core feature of NIDDM, may have more direct effects on cognitive function. High insulin levels increase levels of amyloid-b protein, 12, 13 and amyloidb accumulation in the brain is an early step in the pathogenesis of Alzheimer's disease (AD). 14 In large-scale population-based twin study, diabetes was independently associated with an increased risk of dementia, AD, and vascular dementia. 15 Post-stroke cognitive impairment and dementia are more frequent than traditionally recognized. 16 Moreover, cerebrovascular disease (CVD) is the second most common cause of dementia. 17, 18 Cerebrovascular disease as well as vascular risk factors including arterial hypertension, history of high cholesterol, diabetes, or forms of heart disease are independently associated with an increased risk of cognitive impairment and dementia. 19 While CVD is preventable and treatable, it remains a major factor in the prevalence of cognitive impairment in the elderly individuals worldwide. 20, 21 The current study aimed to evaluate whether, and to what extent, diabetes is interrelated to the overall cognitive status in a large group of patients with ischemic stroke, controlling for the presence of some prevalent comorbidities characteristic of such patients. We hypothesized that patients with ischemic stroke having diabetes might show a lower Mini-Mental State Examination (MMSE) scores, compared with patients without diabetes. Such data would assist in identifying factors associated with cognitive decline and may also assist in evaluating rehabilitation potential and disability risk.
Methods Hypothesis
A diagnosis of DM at admission to a rehabilitation ward would assist in predicting cognitive ability among patients with ischemic stroke.
Design and Setting
The Geriatric Rehabilitation ward at the Sheba Medical Center is a 36-bed unit. This ward uses an interdisciplinary team approach, where representatives from geriatrics, physiotherapy, nursing, rehabilitation therapies (physical, occupational, and speech), social services, and psychology meet twice a week to evaluate the status of each patient. During these meetings, a treatment plan is established and monitored with the purpose of coordinating and integrating staff activities and promoting effective rehabilitation. The patients undergo a typical amount of 6 h/week of physical and occupational therapy (6 d/week).
Study Population
This retrospective study included 707 patients aged !48 years with ischemic stroke. Patients were consecutively admitted to our ward during a 7-year period, after a short stay in the department of internal medicine or neurology. Stroke was diagnosed on the basis of clinical presentation of acute onset of focal neurological signs. Computed tomography (CT) or magnetic resonance imaging (MRI) scans were performed in all cases to confirm the presence of ischemic stroke. Primary inclusion criteria, other than ischemic nature of stroke, included stable medical status (enabling active rehabilitation treatment), and a length of stay and nature of ischemic stroke in the rehabilitation ward of more than 7 days (assuming that a shorter extent of rehabilitation is meaningless). The study sample did not include patients with residual brain damage due to infection, trauma, or surgery and patients with space occupying lesions or hemorrhagic stroke.
The presence of arterial hypertension, ischemic heart disease (manifested as stable or unstable anginal syndrome), atrial fibrillation, previous stroke, DM, and hyperlipidemia were established by medical history, obtained by interview and a complete physical examination.
Cognitive Assessment
Patient's cognitive status was assessed by the MMSE 22 within 1 week after admission to the rehabilitation ward. Mini-Mental State Examination scores lower than 24 points were considered suggestive of cognitive impairment. 23 However, participants were not excluded on the basis of lower limits on the MMSE scores.
Diabetes Mellitus Assessment
The presence or absence of DM was established on registry data positive of DM (International Classification of Diseases, Ninth Revision [ICD-9] code 250.0). This registry data recording system did not allow analysis of glucose levels as continuous variables. Patients with non-insulin-dependent diabetes mellitus were included whether treated by diet, oral hypoglycemic agents, and/or insulin.
Statistical Analysis
Depending on the presence/absence of DM, patients were divided into 2 groups. Comparisons between the groups of patients, as defined above, with regard to demographic and clinical characteristics, were performed using t tests, chisquare test, and linear regression analyses. Potential confounders were evaluated with logistic regression, as applicable. The statistical significance level was set to .05. The SPSS for Windows software, version 11.0, was used for these analyses.
Results
The data of 707 consecutive patients with ischemic stroke (age range 60-96) admitted during a 7-year period were available. The clinicodemographic characteristics of these patients are shown in Table 1 . Mean age was 74.11 + 9.29 years, mostly men (57.1%), whereas mean MMSE scores were 22.45 + 5.42 (Table 1 ). In all, 82 patients (11% of all stroke patients) had pre-stroke dementia by ICD-9, code 294.1. A total of 265 patients (37.5%) were diagnosed to have NIDDM. There were no statistically significant differences between these patients and the remaining nondiabetic patients ( Since a MMSE score !24 defined older age group patients without cognitive impairment, we performed a linear regression analysis to test for predictors of MMSE scores. This showed (Table 2) that NIDDM (P ¼ .004), older age (P < .001), female gender (P < .001), and dementia (P < .001) were independently associated with lower MMSE scores. None of the other variables that we tested, including hypertension, ischemic heart disease, hyperlipidemia, Parkinson's disease, and previous stroke, were predictive of MMSE scores. In addition, logistic regression analysis predicting for cognitive impairment (MMSE < 24), while controlling for confounding variables, showed that NDIDM (OR 1.46; CI 1.05-2.05, P ¼ .02), older age (OR 1.03; CI 1.01-1.05, P ¼ .001), female gender (OR 1.66; CI 1.19-2.32, P ¼ .003), dementia (OR 11, CI 4.93-24.56, P < .001), and previous stroke (O.R. 1.48; C.I. 1.00-2.19, P ¼ .04) were all associated with an increased risk of cognitive impairment (Table 3 ).
Discussion
The area of diabetes and cognitive impairment is fairly new with research developments currently being made. The current study focused on the possible interrelation of NIDDM and cognitive impairment, in a group of patients with a recent onset ischemic stroke. Our data show that NIDDM is associated with lower MMSE scores, thus, indicating cognitive impairment. After multivariate adjustment (for age, gender, ischemic heart disease, hypertension, hyperlipidemia, dementia, Parkinson's disease, and previous stroke), the association between NIDDM and cognitive decline remained evident. These data are consistent with previous studies, showing similar findings in nonstroke-affected patients.
Patients with DM were reported to have a faster decline in global cognitive function, as reflected by the scores of MMSE or Telephone Interview for Cognitive Status (TICS), after 2 to 7 years of follow-up. [24] [25] [26] Prospective population-based studies consistently reported that baseline DM was associated with a faster decline in measures of executive function. [27] [28] [29] Repeated neuropsychological testing of community-dwelling women enrolled in the Study of Osteoporotic Fractures found that self-reported diabetics had worse cognition at baseline and a greater rate of decline over 3 to 6 years. 27 Women with a longer duration of diabetes experienced more decline. Other longitudinal studies have also demonstrated greater cognitive decline in diabetics, 28, 30 with 1 Mexican study finding no relationship. 31 None of these studies has directly compared patients with ischemic stroke with and without DM, despite a priori reasoning that DM may be a potent risk factor for cognitive impairment in this group of patients, given their higher risk of DM-related CVD complications.
Poststroke cognitive impairment is frequent, although it has been a neglected consequence of stroke. An example of a detailed clinical study is the Helsinki Stroke Ageing Study. Cognitive impairment 3 months after ischemic stroke was present in 1 domain in 62% and in 2 domains in 35% of the patients aged 55 to 85 years.
The cognitive domains affected included short-term memory (31%), long-term memory (23%), constructive and visuospatial functions (37%), executive functions (25%), and aphasia (14%). 32 Several potential biological explanations have been proposed for a relationship between DM and diminished cognitive function. One important potential explanation could be DM's indirect effect on cognition through clinical or subclinical vascular disease, because DM is associated with cerebral microvascular and macrovascular damage both of which contribute to cognitive decline. 33 However, there is growing evidence that abnormal insulin regulation a core feature of type 2 DM, may have more direct effects on cognitive function. High insulin levels increase levels of amyloid-b protein, 12, 13 and amyloid-b accumulation in the brain is an early step in the pathogenesis of AD. 34 Several important limitations of the current study are worthy of mention, resulting from its retrospective nature and the fact that this is a single-site study. Also, despite adjustment made for important confounders, still others could have been considered, in particular those relating to other DM markers and illnesses, as well as stroke severity, location, and size. In particular, the data did not allow analysis of glucose levels as continuous variables and did not consider pre-stroke glucose status or a possible change in glucose over time. We also have not incorporated any data of antidiabetes agents. A validation study of registry data, including accuracy of source documents and the level of skill and care applied in abstracting data, was not performed. Finally, longitudinal follow-up data would contribute to a better understanding of the interrelations between diabetes, stroke, and cognition, in later stages. Despite these limitations, the current study is advantageous in the sense that it comprised a relatively large sample of patients, focusing on the possible role of DM on cognitive level among patients with ischemic stroke, thus, is more likely to represent day-to-day clinical practice, rather than just a trial population. We conclude that diabetic patients who suffer ischemic strokes have lower MMSE scores, thus are at increased risk of adverse outcomes. These findings should be considered when selecting and developing resources for diabetic patients.
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